Skip to Content

GSI 704 (Truvada 133 mg / 200 mg)

Generic Name: emtricitabine/tenofovir

Pill with imprint GSI 704 is Blue, Rectangle and has been identified as Truvada 133 mg / 200 mg. It is supplied by Gilead Sciences, Inc..

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 133 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 704

Truvada 133 mg / 200 mg GSI 704

Truvada

Generic Name
emtricitabine/tenofovir
Imprint
GSI 704
Strength
133 mg / 200 mg
Color
Blue
Size
16.00 mm
Shape
Rectangle
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-0704
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, water, FD&C Blue No. 2, aluminum oxide, titanium dioxide, triacetin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.